There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...

DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating on January 21.Invest with Confidence: Follow ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

Alphabet Inc.’s Google has deepened its commitment to artificial intelligence (AI) by investing an additional $1 billion in ...

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...